<DOC>
	<DOCNO>NCT00978874</DOCNO>
	<brief_summary>RATIONALE : Diagnostic procedure , fluorine F 18 EF5 PET/CT imaging , may help find oxygen tumor cell . It may also help doctor predict patient 's response treatment help plan best treatment . PURPOSE : This phase I trial study fluorine F 18 EF5 PET/CT image see well work find hypoxia tumor cell patient locally advance recurrent/metastatic cervical cancer .</brief_summary>
	<brief_title>Fluorine F 18 EF5 PET/CT Imaging Patients With Locally Advanced Recurrent/Metastatic Cervical Cancer</brief_title>
	<detailed_description>OBJECTIVES : - To determine presence heterogeneity hypoxia detect fluorine F 18 EF5 binding tumor PET/CT image patient newly diagnose recurrent carcinoma cervix . - To determine fludeoxyglucose F 18 uptake correlate fluorine F 18 EF5 uptake . - To assess relationship fluorine F 18 EF5 uptake disease-free overall survival . OUTLINE : Patients stratify accord disease stage ( locally advance vs recurrent metastatic disease ) . Patients receive fluorine F 18 EF5 IV follow PET/CT image base skull upper thigh baseline radiotherapy chemotherapy ( i.e. , 3-4 week initiation radiotherapy 4th , 5th , 6th course chemotherapy ) . Patients also undergo fludeoxyglucose F 18 PET/CT image within 7 10 day second fluorine F 18 EF5 scan . After completion study treatment , patient follow 30 day annually thereafter .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Fluorodeoxyglucose F18</mesh_term>
	<mesh_term>Fluorides</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis carcinoma cervix meet 1 follow criterion : Pathologically confirm , newly diagnose stage IBIVA ( locally advance ) disease Imaging evidence recurrent metastatic disease Measurable disease , define ≥ 1 cm anatomic imaging PATIENT CHARACTERISTICS : Karnofsky performance status 70100 % WBC &gt; 2,000/mm³ Platelet count &gt; 90,000/mm³ Total bilirubin &lt; 2.0 mg/dL Creatinine &lt; 2.0 mg/dL Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No history allergic reaction attribute Flagyl ( metronidazole ) No condition personal circumstance , judgment Investigator , may interfere collection complete , goodquality data PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>recurrent cervical cancer</keyword>
	<keyword>stage IB cervical cancer</keyword>
	<keyword>stage IIA cervical cancer</keyword>
	<keyword>stage IIB cervical cancer</keyword>
	<keyword>stage III cervical cancer</keyword>
	<keyword>stage IVA cervical cancer</keyword>
	<keyword>stage IVB cervical cancer</keyword>
</DOC>